{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:33:40Z","timestamp":1792071220415,"version":"4.4.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-55291-x","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T13:24:15Z","timestamp":1735565055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Theranostic Genome"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3188-2125","authenticated-orcid":false,"given":"Xiaoying","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6723-1108","authenticated-orcid":false,"given":"Pablo","family":"Jan\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Taelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2848-3406","authenticated-orcid":false,"given":"Eduardo","family":"Jan\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonathan","family":"Garama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1767-7774","authenticated-orcid":false,"given":"Francisco","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"del Val G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Gariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6487-5349","authenticated-orcid":false,"given":"Martin A.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"55291_CR1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","volume":"18","author":"J Vamathevan","year":"2019","unstructured":"Vamathevan, J. et al. Applications of machine learning in drug discovery and development. Nat. Rev. Drug Discov. 18, 463\u2013477 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"55291_CR2","doi-asserted-by":"publisher","unstructured":"Tropsha, A., Isayev, O., Varnek, A., Schneider, G. & Cherkasov, A. Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR. Nat. Rev. Drug Discov. https:\/\/doi.org\/10.1038\/s41573-023-00832-0 (2023).","DOI":"10.1038\/s41573-023-00832-0"},{"key":"55291_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31245-z","volume":"13","author":"A Pandi","year":"2022","unstructured":"Pandi, A. et al. A versatile active learning workflow for optimization of genetic and metabolic networks. Nat. Commun. 13, 3876 (2022).","journal-title":"Nat. Commun."},{"key":"55291_CR4","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/s42256-023-00751-0","volume":"5","author":"Y Luo","year":"2023","unstructured":"Luo, Y., Liu, Y. & Peng, J. Calibrated geometric deep learning improves kinase\u2013drug binding predictions. Nat. Mach. Intell. 5, 1390\u20131401 (2023).","journal-title":"Nat. Mach. Intell."},{"key":"55291_CR5","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s43588-023-00558-4","volume":"3","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Emerging drug interaction prediction enabled by a flow-based graph neural network with biomedical network. Nat. Computational Sci. 3, 1023\u20131033 (2023).","journal-title":"Nat. Computational Sci."},{"key":"55291_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41557-023-01360-5","author":"DF Nippa","year":"2023","unstructured":"Nippa, D. F. et al. Enabling late-stage drug diversification by high-throughput experimentation with geometric deep learning. Nat. Chem. https:\/\/doi.org\/10.1038\/s41557-023-01360-5 (2023).","journal-title":"Nat. Chem."},{"key":"55291_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s42256-020-00285-9","volume":"3","author":"TH Pham","year":"2021","unstructured":"Pham, T. H., Qiu, Y., Zeng, J., Xie, L. & Zhang, P. A deep learning framework for high-throughput mechanism-driven phenotype compound screening and its application to COVID-19 drug repurposing. Nat. Mach. Intell. 3, 247\u2013257 (2021).","journal-title":"Nat. Mach. Intell."},{"key":"55291_CR8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41571-022-00652-y","volume":"19","author":"L Bodei","year":"2022","unstructured":"Bodei, L., Herrmann, K., Schoder, H., Scott, A. M. & Lewis, J. S. Radiotheranostics in oncology: current challenges and emerging opportunities. Nat. Rev. Clin. Oncol. 19, 534\u2013550 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"55291_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","volume":"19","author":"G Sgouros","year":"2020","unstructured":"Sgouros, G., Bodei, L., McDevitt, M. R. & Nedrow, J. R. Radiopharmaceutical therapy in cancer: clinical advances and challenges. Nat. Rev. Drug Discov. 19, 589\u2013608 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"55291_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nrendo.2011.134","volume":"7","author":"C Reiners","year":"2011","unstructured":"Reiners, C., Hanscheid, H., Luster, M., Lassmann, M. & Verburg, F. A. Radioiodine for remnant ablation and therapy of metastatic disease. Nat. Rev. Endocrinol. 7, 589\u2013595 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"key":"55291_CR11","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa1108586","volume":"366","author":"M Schlumberger","year":"2012","unstructured":"Schlumberger, M. et al. Strategies of radioiodine ablation in patients with low-risk thyroid cancer. N. Engl. J. Med 366, 1663\u20131673 (2012).","journal-title":"N. Engl. J. Med"},{"key":"55291_CR12","doi-asserted-by":"publisher","unstructured":"SSA therapies\u2014177Lu-DOTATATE is a better one in NETTER-1. Nature Reviews Clinical Oncology 12, 684\u2013684, https:\/\/doi.org\/10.1038\/nrclinonc.2015.182 (2015).","DOI":"10.1038\/nrclinonc.2015.182"},{"key":"55291_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa1607427","volume":"376","author":"J Strosberg","year":"2017","unstructured":"Strosberg, J. et al. Phase 3 Trial of (177)Lu-Dotatate for Midgut Neuroendocrine Tumors. N. Engl. J. Med 376, 125\u2013135 (2017).","journal-title":"N. Engl. J. Med"},{"key":"55291_CR14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/d41573-022-00107-0","volume":"21","author":"A Mullard","year":"2022","unstructured":"Mullard, A. What\u2019s next for the synthetic lethality drug discovery engine? Nat. Rev. Drug Discov. 21, 477\u2013479 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"55291_CR15","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJMoa2107322","volume":"385","author":"O Sartor","year":"2021","unstructured":"Sartor, O. et al. Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer. N. Engl. J. Med 385, 1091\u20131103 (2021).","journal-title":"N. Engl. J. Med"},{"key":"55291_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43123-3","volume":"14","author":"P Jane","year":"2023","unstructured":"Jane, P. et al. The Imageable Genome. Nat. Commun. 14, 7329 (2023).","journal-title":"Nat. Commun."},{"key":"55291_CR17","first-page":"D845","volume":"48","author":"J Pinero","year":"2020","unstructured":"Pinero, J. et al. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res 48, D845\u2013D855 (2020).","journal-title":"Nucleic Acids Res"},{"key":"55291_CR18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41586-022-04654-9","volume":"605","author":"L Cao","year":"2022","unstructured":"Cao, L. et al. Design of protein-binding proteins from the target structure alone. Nature 605, 551\u2013560 (2022).","journal-title":"Nature"},{"key":"55291_CR19","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41586-022-05425-2","volume":"611","author":"A Lomakin","year":"2022","unstructured":"Lomakin, A. et al. Spatial genomics maps the structure, nature and evolution of cancer clones. Nature 611, 594\u2013602 (2022).","journal-title":"Nature"},{"key":"55291_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101168","volume":"3","author":"HM Chen","year":"2022","unstructured":"Chen, H. M. & MacDonald, J. A. Network analysis of TCGA and GTEx gene expression datasets for identification of trait-associated biomarkers in human cancer. STAR Protoc. 3, 101168 (2022).","journal-title":"STAR Protoc."},{"key":"55291_CR21","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman, M. J. et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat. Biotechnol. 38, 675\u2013678 (2020).","journal-title":"Nat. Biotechnol."},{"key":"55291_CR22","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Vivian, J. et al. Toil enables reproducible, open source, big biomedical data analyses. Nat. Biotechnol. 35, 314\u2013316 (2017).","journal-title":"Nat. Biotechnol."},{"key":"55291_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ng0797-221","volume":"16","author":"MA Ansari-Lari","year":"1997","unstructured":"Ansari-Lari, M. A., Liu, X. M., Metzker, M. L., Rut, A. R. & Gibbs, R. A. The extent of genetic variation in the CCR5 gene. Nat. Genet 16, 221\u2013222 (1997).","journal-title":"Nat. Genet"},{"key":"55291_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24438-5","volume":"12","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Structural basis for chemokine recognition and receptor activation of chemokine receptor CCR5. Nat. Commun. 12, 4151 (2021).","journal-title":"Nat. Commun."},{"key":"55291_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28130-0","volume":"13","author":"M Claireaux","year":"2022","unstructured":"Claireaux, M. et al. Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry. Nat. Commun. 13, 521 (2022).","journal-title":"Nat. Commun."},{"key":"55291_CR26","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41586-022-04783-1","volume":"606","author":"Y Shen","year":"2022","unstructured":"Shen, Y. et al. CCR5 closes the temporal window for memory linking. Nature 606, 146\u2013152 (2022).","journal-title":"Nature"},{"key":"55291_CR27","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s12350-018-1203-1","volume":"26","author":"L Wei","year":"2019","unstructured":"Wei, L. et al. Development of an inflammation imaging tracer, (111)In-DOTA-DAPTA, targeting chemokine receptor CCR5 and preliminary evaluation in an ApoE(-\/-) atherosclerosis mouse model. J. Nucl. Cardiol. 26, 1169\u20131178 (2019).","journal-title":"J. Nucl. Cardiol."},{"key":"55291_CR28","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1021\/acs.bioconjchem.1c00188","volume":"32","author":"F Li","year":"2021","unstructured":"Li, F., Zeng, Z., Hamilton, D., Zu, Y. & Li, Z. EpCAM-targeting aptamer radiotracer for tumor-specific PET Imaging. Bioconjug Chem. 32, 1139\u20131145 (2021).","journal-title":"Bioconjug Chem."},{"key":"55291_CR29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.2967\/jnumed.110.083386","volume":"53","author":"M Persson","year":"2012","unstructured":"Persson, M. et al. Quantitative PET of human urokinase-type plasminogen activator receptor with 64Cu-DOTA-AE105: implications for visualizing cancer invasion. J. Nucl. Med 53, 138\u2013145 (2012).","journal-title":"J. Nucl. Med"},{"key":"55291_CR30","first-page":"3301","volume":"5","author":"H Zhu","year":"2015","unstructured":"Zhu, H. et al. Radiolabeling and evaluation of (64)Cu-DOTA-F56 peptide targeting vascular endothelial growth factor receptor 1 in the molecular imaging of gastric cancer. Am. J. Cancer Res 5, 3301\u20133310 (2015).","journal-title":"Am. J. Cancer Res"},{"key":"55291_CR31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejpb.2021.08.004","volume":"168","author":"SS Guan","year":"2021","unstructured":"Guan, S. S. et al. A novel (111)indium-labeled dual carbonic anhydrase 9-targeted probe as a potential SPECT imaging radiotracer for detection of hypoxic colorectal cancer cells. Eur. J. Pharm. Biopharm. 168, 38\u201352 (2021).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"55291_CR32","doi-asserted-by":"publisher","first-page":"796","DOI":"10.2967\/jnumed.107.048751","volume":"49","author":"SR Kumar","year":"2008","unstructured":"Kumar, S. R. & Deutscher, S. L. 111In-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors. J. Nucl. Med 49, 796\u2013803 (2008).","journal-title":"J. Nucl. Med"},{"key":"55291_CR33","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s41591-022-01717-2","volume":"28","author":"J Mateo","year":"2022","unstructured":"Mateo, J. et al. Delivering precision oncology to patients with cancer. Nat. Med 28, 658\u2013665 (2022).","journal-title":"Nat. Med"},{"key":"55291_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","volume":"7","author":"RJ Rebello","year":"2021","unstructured":"Rebello, R. J. et al. Prostate cancer. Nat. Rev. Dis. Prim. 7, 9 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"55291_CR35","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s43018-023-00539-6","volume":"4","author":"MK Bakht","year":"2023","unstructured":"Bakht, M. K. et al. Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer. Nat. Cancer 4, 699\u2013715 (2023).","journal-title":"Nat. Cancer"},{"key":"55291_CR36","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2174\/092986706776361049","volume":"13","author":"AR Jalilian","year":"2006","unstructured":"Jalilian, A. R., Bineshmarvasti, M. & Sardari, S. Application of radioisotopes in inflammation. Curr. Med Chem. 13, 959\u2013965 (2006).","journal-title":"Curr. Med Chem."},{"key":"55291_CR37","first-page":"257","volume":"34","author":"K Fellinger","year":"1953","unstructured":"Fellinger, K. [Possibilities and problems of internal treatment of hypertension]. Wien. Z. Inn. Med 34, 257\u2013261 (1953).","journal-title":"Wien. Z. Inn. Med"},{"key":"55291_CR38","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41586-023-06708-y","volume":"623","author":"F Zhang","year":"2023","unstructured":"Zhang, F. et al. Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. Nature 623, 616\u2013624 (2023).","journal-title":"Nature"},{"key":"55291_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.abj6987","volume":"376","author":"S Nurk","year":"2022","unstructured":"Nurk, S. et al. The complete sequence of a human genome. Science 376, 44\u201353 (2022).","journal-title":"Science"},{"key":"55291_CR40","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/nrd2132","volume":"5","author":"P Imming","year":"2006","unstructured":"Imming, P., Sinning, C. & Meyer, A. Drugs, their targets and the nature and number of drug targets. Nat. Rev. Drug Discov. 5, 821\u2013834 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"55291_CR41","doi-asserted-by":"crossref","unstructured":"Mullowney, M. W. et al. Artificial intelligence for natural product drug discovery. Nat. Rev. Drug Discov. 22, 895\u2013916 (2023).","DOI":"10.1038\/s41573-023-00774-7"},{"key":"55291_CR42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41392-022-00994-0","volume":"7","author":"Y You","year":"2022","unstructured":"You, Y. et al. Artificial intelligence in cancer target identification and drug discovery. Signal Transduct. Target Ther. 7, 156 (2022).","journal-title":"Signal Transduct. Target Ther."},{"key":"55291_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41573-022-00561-w","volume":"22","author":"KJ Carss","year":"2023","unstructured":"Carss, K. J. et al. Using human genetics to improve safety assessment of therapeutics. Nat. Rev. Drug Discov. 22, 145\u2013162 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"55291_CR44","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41586-023-05706-4","volume":"616","author":"C Martinez-Ruiz","year":"2023","unstructured":"Martinez-Ruiz, C. et al. Genomic-transcriptomic evolution in lung cancer and metastasis. Nature 616, 543\u2013552 (2023).","journal-title":"Nature"},{"key":"55291_CR45","first-page":"590","volume":"20","author":"WGGeorgCharles Myers","year":"1979","unstructured":"Myers, W. G. GeorgCharles de Hevesy: the father of nuclear medicine. J. Nucl. Med 20, 590\u2013594 (1979).","journal-title":"J. Nucl. Med"},{"key":"55291_CR46","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41591-022-01759-6","volume":"28","author":"C Arnold","year":"2022","unstructured":"Arnold, C. Theranostics could be big business in precision oncology. Nat. Med 28, 606\u2013608 (2022).","journal-title":"Nat. Med"},{"key":"55291_CR47","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41587-021-00954-z","volume":"39","author":"E Dolgin","year":"2021","unstructured":"Dolgin, E. Drugmakers go nuclear, continuing push into radiopharmaceuticals. Nat. Biotechnol. 39, 647\u2013649 (2021).","journal-title":"Nat. Biotechnol."},{"key":"55291_CR48","doi-asserted-by":"crossref","unstructured":"Kwekkeboom, D. J. et al. 177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients. Eur. J. Nucl. Med. 28, 1319\u20131325 (2001).","DOI":"10.1007\/s002590100574"},{"key":"55291_CR49","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41584-023-01042-z","volume":"19","author":"CH Hinze","year":"2023","unstructured":"Hinze, C. H., Foell, D. & Kessel, C. Treatment of systemic juvenile idiopathic arthritis. Nat. Rev. Rheumatol. 19, 778\u2013789 (2023).","journal-title":"Nat. Rev. Rheumatol."},{"key":"55291_CR50","unstructured":"MEDLINE. NLM. MEDLINE PubMed XML element descriptions and their attributes, https:\/\/www.nlm.nih.gov\/bsd\/licensee\/elements_descriptions.html#meshheadinglist (2022)."},{"key":"55291_CR51","unstructured":"MEDLINE. NLM. Download MEDLINE\/PubMed Data, https:\/\/www.nlm.nih.gov\/databases\/download\/pubmed_medline.html (2022)."},{"key":"55291_CR52","unstructured":"64 Entrez Programming Utilities Help [Internet]. Bethesda (MD): National Center for Biotechnology Information (US), https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK25501\/ (2010)."},{"key":"55291_CR53","unstructured":"National Center for Biotechnology Information (US), B. M. Molecular Imaging and Contrast Agent Database (MICAD) [Internet], https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK5330\/ (2004\u20132013)."},{"key":"55291_CR54","unstructured":"Cheng, K. T. in Molecular Imaging and Contrast Agent Database (MICAD) (National Center for Biotechnology Information (US), 2004)."},{"key":"55291_CR55","doi-asserted-by":"publisher","unstructured":"Honnibal, M., Montani, I., Van Landeghem, S. & Boyd, A. spaCy: Industrial-Strength Natural Language Processing in Python, https:\/\/doi.org\/10.5281\/zenodo.1212303 (2020).","DOI":"10.5281\/zenodo.1212303"},{"key":"55291_CR56","doi-asserted-by":"crossref","unstructured":"Neumann, M., King, D., Beltagy, I. & Ammar, W. ScispaCy: Fast and Robust Models for Biomedical Natural Language Processing. (Association for Computational Linguistics, 2019).","DOI":"10.18653\/v1\/W19-5034"},{"key":"55291_CR57","unstructured":"MySQL. MySQL 8.0 Reference Manual, https:\/\/dev.mysql.com\/doc\/refman\/8.0\/en\/ (2023)."},{"key":"55291_CR58","unstructured":"pypi.org. mygene 3.2.2, https:\/\/pypi.org\/project\/mygene\/ (2021)."},{"key":"55291_CR59","unstructured":"OpenAI et al. GPT-4 Technical Report. arXiv:2303.08774. https:\/\/ui.adsabs.harvard.edu\/abs\/2023arXiv230308774O (2023)."},{"key":"55291_CR60","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","volume":"30","author":"Z Gu","year":"2014","unstructured":"Gu, Z., Gu, L., Eils, R., Schlesner, M. & Brors, B. circlize Implements and enhances circular visualization in R. Bioinformatics 30, 2811\u20132812 (2014).","journal-title":"Bioinformatics"},{"key":"55291_CR61","doi-asserted-by":"publisher","unstructured":"Gu, Z. Complex heatmap visualization. iMeta 1, https:\/\/doi.org\/10.1002\/imt2.43 (2022).","DOI":"10.1002\/imt2.43"},{"key":"55291_CR62","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","volume":"25","author":"G Bindea","year":"2009","unstructured":"Bindea, G. et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25, 1091\u20131093 (2009).","journal-title":"Bioinformatics"},{"key":"55291_CR63","doi-asserted-by":"publisher","unstructured":"UniProt, C. UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res 51, D523-D531, https:\/\/doi.org\/10.1093\/nar\/gkac1052 (2023).","DOI":"10.1093\/nar\/gkac1052"},{"key":"55291_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34630-w","volume":"13","author":"RC Edgar","year":"2022","unstructured":"Edgar, R. C. Muscle5: High-accuracy alignment ensembles enable unbiased assessments of sequence homology and phylogeny. Nat. Commun. 13, 6968 (2022).","journal-title":"Nat. Commun."},{"key":"55291_CR65","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/molbev\/msaa015","volume":"37","author":"BQ Minh","year":"2020","unstructured":"Minh, B. Q. et al. IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era. Mol. Biol. Evol. 37, 1530\u20131534 (2020).","journal-title":"Mol. Biol. Evol."},{"key":"55291_CR66","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nmeth.4285","volume":"14","author":"S Kalyaanamoorthy","year":"2017","unstructured":"Kalyaanamoorthy, S., Minh, B. Q., Wong, T. K. F., von Haeseler, A. & Jermiin, L. S. ModelFinder: fast model selection for accurate phylogenetic estimates. Nat. Methods 14, 587\u2013589 (2017).","journal-title":"Nat. Methods"},{"key":"55291_CR67","doi-asserted-by":"publisher","first-page":"W293","DOI":"10.1093\/nar\/gkab301","volume":"49","author":"I Letunic","year":"2021","unstructured":"Letunic, I. & Bork, P. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res 49, W293\u2013W296 (2021).","journal-title":"Nucleic Acids Res"},{"key":"55291_CR68","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s10822-005-8694-y","volume":"19","author":"IV Tetko","year":"2005","unstructured":"Tetko, I. V. et al. Virtual computational chemistry laboratory\u2013design and description. J. Comput Aided Mol. Des. 19, 453\u2013463 (2005).","journal-title":"J. Comput Aided Mol. Des."},{"key":"55291_CR69","unstructured":"Tetko, D. I. V. VCCLAB, Virtual Computational Chemistry Laboratory, https:\/\/vcclab.org."},{"key":"55291_CR70","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1021\/ci025515j","volume":"42","author":"IV Tetko","year":"2002","unstructured":"Tetko, I. V. & Tanchuk, V. Y. Application of associative neural networks for prediction of lipophilicity in ALOGPS 2.1 program. J. Chem. Inf. Comput Sci. 42, 1136\u20131145 (2002).","journal-title":"J. Chem. Inf. Comput Sci."},{"key":"55291_CR71","doi-asserted-by":"publisher","unstructured":"Bac Resource Consortium, T. et al. Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature 409, 953\u2013958 https:\/\/doi.org\/10.1038\/35057192 (2001).","DOI":"10.1038\/35057192"},{"key":"55291_CR72","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13, 2498\u20132504 (2003).","journal-title":"Genome Res"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55291-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55291-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55291-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T04:02:24Z","timestamp":1735617744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55291-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["55291"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-55291-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"25 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10904"}}